MAZE Competitors & Alternatives
Compare Maze Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MAZE
Main Stock$29.66
Tradestie Score
62
Market Cap
$1.13B
Analyst Upside
+110.9%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.66
|
$1.81B | - | 62 | Compare |
|
MPLT
MPLT
|
$36.74
|
$1.78B | - | 63 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$6.53
|
$1.78B | - | 59 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$23.70
|
$1.78B | - | 63 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$19.04
|
$1.74B | - | 61 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$38.80
|
$1.68B | - | 62 | Compare |
|
MNKD
Mannkind Corporation
|
$3.98
|
$1.65B | - | 51 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$39.39
|
$1.63B | - | 64 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.00
|
$1.57B | - | 59 | Compare |
|
VCEL
Vericel Corporation
|
$46.29
|
$1.56B | 109.3 | 61 | Compare |
More MAZE Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2836)
229 stocks in this industry